



| Catalog No. | HY598016 |
|---|---|
| Description |
Sutimlimab (HY598016) is a research-grade recombinant antibody targeting C1 esterase. Produced in mammalian cells with native-like glycosylation.
Highlights
|
| Species reactivity | Human |
| Applications | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| Host species | Human |
| Isotype | IgG4-kappa |
| Expression system | Mammalian cells |
| Clonality | Monoclonal |
| Target | C1 esterase, Complement C1s subcomponent, C1S, Complement component 1 subcomponent s |
| Endotoxin level | Please contact the lab for this information. |
| Purity | >95% purity as determined by SDS-PAGE. |
| Purification | Protein A/G purified from cell culture supernatant. |
| Accession | P09871 |
| Form | Liquid |
| Storage buffer | 0.01M PBS pH 7.4 Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA. |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| Alternate Names | BIVV009, IPN-009, TNT009, 2049079-64-1 |
| Background | Complement C1s subcomponent is a ~76 kDa protein. Component of the complement C1 complex, a multiprotein complex that initiates the classical pathway of the complement system, a cascade of proteins that leads to phagocytosis and breakdown of pathogens and signaling that strengthens the adaptive immune system. C1S is activated following association of the C1 complex with immunoglobulins (IgG or IgM) complexed with antigens to form antigen-antibody complexes on the surface of pathogens. C1S is cleaved and activated by C1R to generate C1s subcomponent heavy and light chains. C1s subcomponent light chain then cleaves and activates C2 and C4, the next components of the classical complement pathway. 1. Lacroix, M. et al. (2001) The Journal of biological chemistry 276, 36233-40. PMID: 11445589 2. Kerr, FK. et al. (2005) The Journal of biological chemistry 280, 39510-4. PMID: 16169853 3. Kerr, MA. et al. (1978) The Biochemical journal 171, 99-107. PMID: 417728 4. Reboul, A. et al. (1979) FEBS letters 103, 156-61. PMID: 467643 5. McRae, BJ. et al. (1981) The Journal of biological chemistry 256, 12362-6. PMID: 6271784 6. Thielens, NM. et al. (1982) FEBS letters 141, 19-24. PMID: 6282646 7. Thielens, NM. et al. (1984) FEBS letters 165, 111-6. PMID: 6319179 8. Nagasawa, S. et al. (1977) Proceedings of the National Academy of Sciences of the United States of America 74, 2998-3001. PMID: 70787 9. Rossi, V. et al. (1998) The Journal of biological chemistry 273, 1232-9. PMID: 9422791 10. Zwarthoff, SA. et al. (2021) Proceedings of the National Academy of Sciences of the United States of America 118. PMID: 34155115 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |

SEC-HPLC detection for Research Grade Sutimlimab.

SDS-PAGE for Research Grade Sutimlimab.




Contact us for custom quotes, bulk requests and any other issues.
Mail: support@abinScience.com




+86-27-87433958
Building C, No. 666, Shen Dun Si Lu, Wuhan, 430206, China
中文
English
한국어
日本語
Español
Français
Русский